Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 6:14:1-4.
doi: 10.1016/j.gdata.2017.07.004. eCollection 2017 Dec.

Genome-wide miRNA, gene and methylation analysis of triple negative breast cancer to identify changes associated with lymph node metastases

Affiliations

Genome-wide miRNA, gene and methylation analysis of triple negative breast cancer to identify changes associated with lymph node metastases

Kelly A Avery-Kiejda et al. Genom Data. .

Abstract

Triple negative breast cancer (TNBC) is a particularly important breast cancer subtype with an aggressive clinical phenotype that is associated with a higher likelihood of metastasis. This subtype is characterized by an absence of the estrogen (ER) and progesterone (PR) receptors, as well as the human epidermal growth factor receptor 2 (HER2/HER neu). The absence of the three receptors significantly reduces targeted treatment options for patients with TNBC and as such, there is an urgent need to identify novel treatment targets. Here, we provide detailed information regarding the design of a multi-platform dataset that describes genome-wide assessment of miRNA (assessed by microarray, GSE38167) and gene expression (assessed by microarray, GSE61723), as well as methylation (assessed by Illumina HM450K BeadChip, GSE78751) in TNBCs, matched normal adjacent tissues and matched lymph node metastases. The use of this multi-platform dataset is likely to uncover novel markers and key pathways involved in progression to lymph node metastasis in TNBC.

PubMed Disclaimer

References

    1. Avery-Kiejda K.A., Braye S.G., Mathe A., Forbes J.F., Scott R.J. Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer. BMC Cancer. 2014;14(1):51. - PMC - PubMed
    1. Mathe A., Wong-Brown M., Locke W.J., Stirzaker C., Braye S.G., Forbes J.F., Clark S.J., Avery-Kiejda K.A., Scott R.J. DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients. Sci Rep. 2016;6:33435. - PMC - PubMed
    1. Mathe A., Wong-Brown M., Morten B., Forbes J.F., Braye S.G., Avery-Kiejda K.A., Scott R.J. Novel genes associated with lymph node metastasis in triple negative breast cancer. Sci Rep. 2015;5:15832. - PMC - PubMed
    1. Carter C.L., Allen C., Henson D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63(1):181–187. - PubMed
    1. Hernandez-Aya L.F., Chavez-Macgregor M., Lei X., Meric-Bernstam F., Buchholz T.A., Hsu L., Sahin A.A., Do K.A., Valero V., Hortobagyi G.N., Gonzalez-Angulo A.M. Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer. J. Clin. Oncol. 2011;29(19):2628–2634. - PMC - PubMed